According to filings with the U.S. Securities and Exchange Commission, Bion Environmental Technologies is raising up to $6,000,000.00 in new funding. Sources indicate that as part of senior management President, Mark Smith played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Bion Environmental Technologies
We are committed to improving the health of people worldwide with our fundamental research and development of immunotherapies. We believe in scientific rigor, innovation and passion as driving force. BioNTech was founded by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. We at BioNTech believe that the immune system is the fundamental driver for therapeutic success in cancer and infectious diseases. As immune engineers we have a deep understanding of the underlying mechanisms that enable the immune system to effectively recognize both external threats like infectious diseases and internal threats like cancer. Our goal is to translate this expertise into therapies and vaccines that can make a difference for individuals as well as humankind.

To learn more about Bion Environmental Technologies, visit http://www.bionenviro.com/

Contact:
Mark Smith, President
516-249-5682

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.